BridgeMD
Tests treatment safety and results for Peri-Implantitis
Official title Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis
ClinicalTrials.gov ID: NCT05899933
What this study is testing
- What it's testing
- The purpose of the present study is to compare the 1-year clinical, radiographic and microbiological outcomes and patients' satisfaction following surgical treatment of peri-implantitis after applying two different surface modification methods. Secondarily, analysis and comparison of the microbiological results of implants diagnosed and treated for peri-implantitis with healthy implants will be performed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- General
- Participants ≥ 18 years and ≤ 80 years of age
- Non-smokers based on the patients' self-reported smoking status, defined as patients who had never smoked or had quit smoking at least 2 years ago
- Implants in function for more than 1 year after suprastructure connection for implants diagnosed with Peri-Implantitis:
- Presence of at least one implant diagnosed with peri-implantitis defined as presence of bleeding on probing and/or suppuration, probing pocket depth...
You likely can't join if
- Smokers
- Uncontrolled diabetes mellitus (HBA1c \>7)
- Treatment with bisphosphonates
- Needing antibiotic prophylaxis
- Currently pregnant or breast-feeding women
- History of systemic administration of antibiotic treatment during the preceding 3 months
See the full eligibility criteria
- General
- Participants ≥ 18 years and ≤ 80 years of age
- Non-smokers based on the patients' self-reported smoking status, defined as patients who had never smoked or had quit smoking at least 2 years ago
- Implants in function for more than 1 year after suprastructure connection for implants diagnosed with Peri-Implantitis:
- Presence of at least one implant diagnosed with peri-implantitis defined as presence of bleeding on probing and/or suppuration, probing pocket depth ≥6 mm and ≥3 mm of detectable bone loss after initial re-modelling
- Absence of implant mobility
- in participants with more than one implant, the implant with the worst clinical condition will be studied. for implants diagnosed with Peri-Implant Health:
- Absence of peri-implant signs of inflammation (redness, swelling)
- Lack of bleeding on probing
- Absence of bone loss beyond crestal bone level changes resulting from initial remodeling, which should not be ≥2 mm
- Smokers
- Uncontrolled diabetes mellitus (HBA1c \>7)
- Treatment with bisphosphonates
- Needing antibiotic prophylaxis
- Currently pregnant or breast-feeding women
- History of systemic administration of antibiotic treatment during the preceding 3 months
- Systemic conditions that contraindicate treatment
- Use of medications known to induce gingival hyperplasia
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.